Survey: 92% of Americans Open to Treatments Slowing Disease Progression
A recent survey indicates that a significant majority of Americans express willingness to consider treatments aimed at slowing down the advancement of diseases. Specifically, the survey revealed that 92% of Americans are open to exploring such therapeutic interventions. This finding stems from a survey conducted across the United States. The study focused on gauging public sentiment towards medical interventions designed to mitigate the progression of various diseases, and the results show that over 9 out of 10 Americans would consider these options.
Newsflash | Powered by GeneOnline AI
Date: May 2, 2025
LATEST
VintaBio Showcases High-Yield VintaProcess Platform for Gene Therapy Vector Production at ASGCT 2025
2025-05-15
Boehringer Ingelheim and Tempus AI Partner in Multi-Year Collaboration to Enhance Oncology Drug Development
2025-05-15
Study: Aligning U.S. Drug Prices with Europe Could Reduce American Life Expectancy by Six Months
2025-05-15